Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 62019TN0678

    Case T-678/19: Action brought on 4 October 2019 – Health Product Group v EUIPO – Bioline Pharmaceutical (Enterosgel)

    IO C 399, 25.11.2019, p. 99–99 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

    25.11.2019   

    EN

    Official Journal of the European Union

    C 399/99


    Action brought on 4 October 2019 – Health Product Group v EUIPO – Bioline Pharmaceutical (Enterosgel)

    (Case T-678/19)

    (2019/C 399/117)

    Language of the case: English

    Parties

    Applicant: Health Product Group sp. z o.o. (Warsaw, Poland) (represented by: M. Kondrat, lawyer)

    Defendant: European Union Intellectual Property Office (EUIPO)

    Other party to the proceedings before the Board of Appeal: Bioline Pharmaceutical AG (Baar, Switzerland)

    Details of the proceedings before EUIPO

    Proprietor of the trade mark at issue: Other party to the proceedings before the Board of Appeal

    Trade mark at issue: International registration designating the European Union in respect of the word mark Enterosgel – International registration designating the European Union No 896 788

    Procedure before EUIPO: Cancellation proceedings

    Contested decision: Decision of the Fourth Board of Appeal of EUIPO of 8 August 2019 in Case R 482/2018-4

    Form of order sought

    The applicant claims that the Court should:

    annul the contested decision and cancel the trade mark;

    award the costs in applicant’s favour.

    Plea in law

    Infringement of Article 59(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.


    Top